SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ANUH PHARMA

BSE: 506260 19 Aug 2025
Healthcare
₹ 88.37
Anuh Pharma Ltd., specializes in Pharmaceuticals within the Healthcare sector.

ANUH PHARMA - Share Price & Details

Market Cap
₹885.0
High /Low
123.0 / 74.0
Stock P/E
19.2
Book Value
₹32.5
Dividend Yield
1.7
ROCE
17.2
ROE
₹13.4
Face Value
5.0
PEG Ratio
1.46
EVEBITDA
₹12.6
Debt
10.9
CMP / FCF
34.4
Debt to equity
₹0.03
NP Ann
47.4
High price all time
133.0
Piotroski score
₹4.0
Graham Number
58.1
No. Eq. Shares
10.0
Net CF
₹12.4
Net profit
46.1
Price to book value
2.72
Interest Coverage
₹88.8
Low price all time
3.41
Industry PE
33.8
Reserves
₹301
Free Cash Flow
₹17.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
ANUH PHARMA LTD.1898.6883.011864.791.66885.019.2
Sastasundar Ventures Limited3.54-1.090.97-0.0387924.5
Shukra Pharmaceuticals Limited147.3553.87132.700.1286685.6

Peer Comparison Chart


About ANUH PHARMA

Anuh Pharma Ltd.,, with Security Code 506260, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Anuh Pharma Reports Mixed Financial Results Amidst Sales Growth and Profitability Challenges

(09 Aug 2025)
Anuh Pharma has released its financial results for the quarter ending June 2025, revealing a year-on-year net sales growth of 27.44% to Rs...
Read more →

Anuh Pharma standalone net profit declines 12.72% in the June 2025 quarter

(08 Aug 2025)
Net profit of Anuh Pharma declined 12.72% to Rs 8.30 crore in the quarter ended June 2025 as against Rs 9.51 crore during the previous quarter ended June...
Read more →

We Think That There Are More Issues For Anuh Pharma (NSE:ANUHPHR) Than Just Sluggish Earnings

(06 Aug 2025)
The subdued market reaction suggests that Anuh Pharma Limited's (NSE:ANUHPHR) recent earnings didn't contain any surprises.
Read more →

Anuh Pharma Faces Mixed Technical Trends Amid Underperformance and Flat Financial Results

(05 Aug 2025)
Anuh Pharma, a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation due to shifts in...
Read more →

Anuh Pharma Limited (506260) Expands into New Market - Build wealth steadily with proven investment techniques

(04 Aug 2025)
Anuh Pharma Limited (506260) Expands into New Market ✌️【Investor Updates】✌️ Our real-time investment engine analyzes global stocks,...
Read more →

Is Anuh Pharma Limited (506260) a Good Long Term Bet - Capitalize on emerging industry trends

(04 Aug 2025)
Is Anuh Pharma Limited (506260) a Good Long Term Bet ✌️【Market Discussions】✌️ Use our platform to cut through the noise and focus on real...
Read more →

Company Updates